Shanghai Roche announces Avastin OK in China

Joint venture Shanghai Roche Pharma has announced Chinese approval for cancer treatment Avastin. The announcement follows by a week the news of an Avastin fake used as a treatment for eye disease causing adverse reactions in more than half of those given the knockoff. Article

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.